Alpa Laboratories Limited (NSE:ALPA)
61.00
-1.62 (-2.59%)
Sep 11, 2026, 3:29 PM IST
Alpa Laboratories Revenue
Alpa Laboratories had revenue of 239.31M INR in the quarter ending June 30, 2026, with 25.22% growth. This brings the company's revenue in the last twelve months to 1.11B, up 0.46% year-over-year. In the fiscal year ending March 31, 2026, Alpa Laboratories had annual revenue of 1.06B, down -5.91%.
Revenue (ttm)
1.11B
Revenue Growth
+0.46%
P/S Ratio
1.17
Revenue / Employee
2.44M
Employees
453
Market Cap
1.30B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.06B | -66.42M | -5.91% |
| Mar 31, 2025 | 1.12B | 37.13M | 3.41% |
| Mar 31, 2024 | 1.09B | 157.84M | 16.98% |
| Mar 31, 2023 | 929.55M | -193.11M | -17.20% |
| Mar 31, 2022 | 1.12B | 147.12M | 15.08% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Valiant Laboratories | 3.06B |
| Amanta Healthcare | 2.91B |
| Balaxi Pharmaceuticals | 2.80B |
| Anlon Healthcare | 2.26B |
| Bafna Pharmaceuticals | 1.43B |
| Par Drugs and Chemicals | 1.09B |
| Vaishali Pharma | 1.08B |
| Brooks Laboratories | 831.87M |